Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls.


Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
Apr 2021
Historique:
pubmed: 5 3 2021
medline: 7 10 2021
entrez: 4 3 2021
Statut: ppublish

Résumé

For selection of high-risk systemic lupus erythematosus (SLE) patients it is necessary to obtain indicators of disease severity that predict disease damage. As in systemic sclerosis, nailfold capillary abnormalities could be such a biomarker in SLE. The primary objective of this cross-sectional study is to describe capillary abnormalities in childhood-onset SLE (cSLE) cohort (onset < 18 years) and compare them with matched healthy controls. The secondary objective is to correlate the observed capillary abnormalities with demographical variables in both cohorts and with disease-specific variables in cSLE patients. Healthy controls were matched for ethnic background, age and gender. Videocapillaroscopy was performed in eight fingers with 2-4 images per finger. Quantitative and qualitative assessments of nailfold capillaroscopy images were performed according to the definitions of the EULAR study group on microcirculation in Rheumatic Diseases. Both groups (n = 41 cSLE-patients and n = 41 healthy controls) were comparable for ethnic background (p = 0.317). Counted per mm, cSLE-patients showed significantly more 'giants' (p = 0.032), 'abnormal capillary shapes' (p = 0.003), 'large capillary hemorrhages' (p < 0.001) and 'pericapillary extravasations' (p < 0.001). Combined 'abnormal capillary shapes and pericapillary extravasations' (in the same finger) were detected in 78% (32/41 patients). By qualitative analysis, 'microangiopathy' was detected in 68.3% (28/41) and a 'scleroderma pattern' in 17.1% (7/41) of the cSLE-patients (without scleroderma symptoms). The difference of percentage positive anti-RNP antibodies in the group with or without a scleroderma pattern was not significant (p = 0.089). The number of 'abnormal capillary shapes per mm' was significantly correlated with treatment-naivety. The number of 'large pathological hemorrhages per mm' was significantly correlated with SLEDAI score and presence of nephritis. Compared to healthy controls, 'pericapillary extravasations' were found in significantly higher numbers per mm (p < 0.001) as well as in percentage of patients (p < 0.001). Our observations confirm that giants, abnormal capillary morphology and capillary hemorrhages are also observed in cSLE, as was already known for adults with SLE. Number of capillary hemorrhages in cSLE was significantly correlated with disease activity. A high frequency and total amount of "pericapillary extravasations" was observed in cSLE patients, possibly revealing a new subtype of capillary hemorrhage that might reflect endothelial damage in these pediatric patients.

Identifiants

pubmed: 33657918
doi: 10.1177/0961203321998750
pmc: PMC8020305
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-827

Références

Arthritis Rheum. 1980 Feb;23(2):183-9
pubmed: 7362667
Clin Rheumatol. 2013 Jun;32(6):839-43
pubmed: 23417347
Ann Rheum Dis. 2014 Jun;73(6):958-67
pubmed: 24739325
Autoimmun Rev. 2020 Mar;19(3):102458
pubmed: 31927087
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Semin Arthritis Rheum. 1990 Aug;20(1):21-31
pubmed: 2218550
Lupus. 2017 Aug;26(9):959-966
pubmed: 28056626
RMD Open. 2017 Oct 25;3(2):e000508
pubmed: 29119007
Am J Med. 1992 Dec;93(6):619-27
pubmed: 1466357
Autoimmun Rev. 2019 Nov;18(11):102394
pubmed: 31520797
Clin Rheumatol. 2017 Feb;36(2):343-350
pubmed: 28012055
Autoimmun Rev. 2018 Apr;17(4):344-352
pubmed: 29427827
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
RMD Open. 2018 Nov 27;4(2):e000793
pubmed: 30564454
Ann Rheum Dis. 2012 Oct;71(10):1636-9
pubmed: 22402146
Semin Arthritis Rheum. 1999 Aug;29(1):36-42
pubmed: 10468413
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):350-354
pubmed: 31858964
Semin Arthritis Rheum. 2010 Feb;39(4):257-68
pubmed: 19136143
Lupus Sci Med. 2018 May 14;5(1):e000237
pubmed: 29765616
Rheumatology (Oxford). 2007 Oct;46(10):1566-9
pubmed: 17693443
Rheumatology (Oxford). 2017 Apr 1;56(suppl_1):i67-i77
pubmed: 27940583
Semin Arthritis Rheum. 2019 Oct;49(2):267-272
pubmed: 31235075
Ann Rheum Dis. 2009 Jan;68(1):94-8
pubmed: 18308744
Lupus. 2015 Oct;24(12):1342-9
pubmed: 26085595
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):788-94
pubmed: 26575830
Rheumatology (Oxford). 2018 Apr 1;57(4):757-759
pubmed: 29361155
Lupus. 2016 Dec;25(14):1542-1550
pubmed: 27147622
J Rheumatol. 2002 Jul;29(7):1398-400
pubmed: 12136895
Arthritis Rheum. 1973 Sep-Oct;16(5):619-28
pubmed: 4742842
Autoimmun Rev. 2017 Aug;16(8):774-786
pubmed: 28572048
Biomed Res Int. 2014;2014:178721
pubmed: 24790989
Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):63-68
pubmed: 31172926
Rheumatol Int. 2016 Jul;36(7):955-60
pubmed: 26979603
Rheumatology (Oxford). 2016 May;55(5):883-90
pubmed: 26843483
J Rheumatol. 2013 Dec;40(12):2023-8
pubmed: 24128778
J Clin Rheumatol. 2005 Dec;11(6):295-8
pubmed: 16371797
Ann Rheum Dis. 2008 Jun;67(6):885-7
pubmed: 18037628
Pediatr Rheumatol Online J. 2019 Oct 24;17(1):69
pubmed: 31651352

Auteurs

Dieneke Schonenberg-Meinema (D)

Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Sandy C Bergkamp (SC)

Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Amara Nassar-Sheikh Rashid (A)

Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Leontien B van der Aa (LB)

Department of Pediatric Rheumatology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.

Godelieve J de Bree (GJ)

Department of Infectious Diseases, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, the Netherlands.

Rebecca Ten Cate (R)

Department of Pediatric Rheumatology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.

Maurizio Cutolo (M)

Department of Internal Medicine, Research Laboratory and Academic Division of Clinical Rheumatology, IRCCS Polyclinic San Martino Hospital, University of Genova, Genova, Italy.

A Elisabeth Hak (AE)

Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Centre, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Petra Ce Hissink Muller (PC)

Department of Pediatric Rheumatology, Leiden University Medical Centre (LUMC), Leiden, the Netherlands.

Marieke van Onna (M)

Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Centre, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Taco W Kuijpers (TW)

Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Vanessa Smith (V)

Department of Rheumatology, Ghent University Hospital, Belgium.
Faculty of Internal Medicine, Ghent University, Ghent, Belgium.
Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Centre (IRC), Ghent, Belgium.

J Merlijn van den Berg (JM)

Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH